IPSEN, OOO

🇷🇺Russia
Ownership
-
Established
1929-01-01
Employees
5.7K
Market Cap
$9.8B
Website
https://www.ipsen.com/

A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer

Completed
Conditions
First Posted Date
2011-06-28
Last Posted Date
2019-01-14
Lead Sponsor
Ipsen
Target Recruit Count
180
Registration Number
NCT01383863
Locations
🇱🇹

Medical University Clinics, Kaunas, Lithuania

🇷🇴

Sc E-Uro Srl, Cluj Napoca, Romania

🇬🇧

Nottingham City Hospital, Nottingham, United Kingdom

and more 32 locations

Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer

First Posted Date
2011-06-15
Last Posted Date
2019-09-18
Lead Sponsor
Ipsen
Target Recruit Count
32
Registration Number
NCT01374087
Locations
🇪🇸

H. Sanchinarro, Madrid, Spain

🇪🇸

H. Ramón y Cajal, Madrid, Spain

🇪🇸

H. de la Santa Creu i Sant Pau, Barcelona, Spain

and more 8 locations

Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis

First Posted Date
2011-05-23
Last Posted Date
2022-09-27
Lead Sponsor
Ipsen
Target Recruit Count
47
Registration Number
NCT01357980
Locations
🇫🇷

Hopital Tenon, Paris, France

🇫🇷

Hôpital Lyon Sud -Hospices Civils de Lyon, Lyon, France

🇵🇱

NZOZ Centrum Medyczne Mazovia, Warszawa, Poland

and more 14 locations

A Study of the Potential Risk Factors Linked to the Development of Severe Forms of Endometriosis

Completed
Conditions
First Posted Date
2011-05-10
Last Posted Date
2019-01-14
Lead Sponsor
Ipsen
Target Recruit Count
1008
Registration Number
NCT01351051
Locations
🇨🇳

Women's Hospital School of Medicine, Zhejiang University, Zhejiang, China

🇷🇺

Research Institute of Maternity and Childhood named after V.N. Gorodkov, Ivanovo, Russian Federation

🇨🇳

Peking Union Medical College Hospital, Beijing, China

and more 4 locations

Safety and Efficacy Study of Dysport RU and Glabellar Lines

First Posted Date
2011-04-12
Last Posted Date
2022-09-27
Lead Sponsor
Ipsen
Target Recruit Count
176
Registration Number
NCT01333397
Locations
🇫🇷

Private practice, Paris, France

🇩🇪

Charité hospital, Berlin, Germany

🇩🇪

Private clinic, Starnberg, Germany

Study in Polish Acromegalic Patients Treated With Somatuline Autogel

Completed
Conditions
First Posted Date
2011-04-12
Last Posted Date
2019-01-07
Lead Sponsor
Ipsen
Target Recruit Count
150
Registration Number
NCT01333384
Locations
🇵🇱

Ipsen Central Contact, Warsaw, Poland

DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia

Completed
Conditions
First Posted Date
2011-03-14
Last Posted Date
2020-11-05
Lead Sponsor
Ipsen
Target Recruit Count
350
Registration Number
NCT01314365
Locations
🇺🇸

The Parkinson's and Movement Disorders Center, Southfield, Michigan, United States

🇺🇸

Methodist Rehabilitation Center, Jackson, Mississippi, United States

🇺🇸

Gershon Pain Specialists, Virginia Beach, Virginia, United States

and more 42 locations

Dysport® Adult Upper Limb Spasticity

First Posted Date
2011-03-11
Last Posted Date
2022-09-28
Lead Sponsor
Ipsen
Target Recruit Count
243
Registration Number
NCT01313299
Locations
🇭🇺

Petz Aladar County Hospital, Gyor, Hungary

🇷🇺

Medical Rehabilitation Center, Moscow, Russian Federation

🇸🇰

Univerzitna nemocnica Bratislava, Bratislava, Slovakia

and more 36 locations

Dysport® Adult Upper Limb Spasticity Extension Study

Phase 3
Completed
Conditions
Interventions
First Posted Date
2011-03-11
Last Posted Date
2022-09-28
Lead Sponsor
Ipsen
Target Recruit Count
258
Registration Number
NCT01313312
Locations
🇵🇱

Malopolskie Centrum Medyczne, Krakow, Poland

🇷🇺

State University, St Petersburg, Russian Federation

🇸🇰

Derer's Hospital, Bratislava, Slovakia

and more 31 locations

Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients

First Posted Date
2011-03-11
Last Posted Date
2019-11-22
Lead Sponsor
Ipsen
Target Recruit Count
3
Registration Number
NCT01313273
Locations
🇮🇹

A.O. S. Luigi Gonzaga, Orbassano ( TO), Italy

© Copyright 2024. All Rights Reserved by MedPath